» Articles » PMID: 31192083

Identification of Novel Glycoside Hydrolases Via Whole Genome Sequencing of for Production of Various Minor Ginsenosides

Overview
Journal 3 Biotech
Publisher Springer
Specialty Biotechnology
Date 2019 Jun 14
PMID 31192083
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, many bacterial strains were screened for the production of minor ginsenosides, but based on conversion competence among the strains, the strain BS26 has the good ginsenoside-transforming ability. Therefore, the strain BS26 was selected for complete genome sequence analysis to determine the target (glycoside hydrolase) functional genes. Whole genome analysis of strain BS26 showed 43 glycoside hydrolase genes in total. To determine the target functional gene, 12 sets of six different glycoside hydrolases (3 set of β-glucosidase; 3 set of trehalase; 3 set of arabinofuranosidase; 2 set of xylosidase; and one set of each α-galactosidase and α-fucosidase, respectively) were selected and cloned in BL21 (DE3) using the pGEX4T-1 vector and were characterized. Among these 12 sets of clones, only one, β-glucosidase (BglNg-767), showed ginsenoside conversion ability. The BglNg-767 comprised 767 amino acids and belonged to glycoside hydrolase family 3 (GH3). The recombinant GST-BglNg-767 was capable of altering the ginsenosides Rb, Rd, and gypenoside XVII (Gyp-XVII) to F; Rb to C-O; Rb to C-Mx1, and Rc to C-Mc1. Besides, complete genome sequence analysis of strain BS26 also indicates 30 endopeptidase genes, which may be responsible for self-hydrolysis of the proteins. Therefore, using SDS-PAGE analysis, we predict that the difference between the molecular weight of the expressed protein (around 90 kDa) and the predicted amino-acid sequence (102.7 kDa) is due to self-hydrolysis of the proteins.

Citing Articles

Biosynthesis of a Novel Ginsenoside with High Anticancer Activity by Recombinant UDP-Glycosyltransferase and Characterization of Its Biological Properties.

Wang D, Jin Y, Wang H, Zhang C, Li Y, Subramaniyam S Molecules. 2025; 30(4).

PMID: 40005208 PMC: 11858633. DOI: 10.3390/molecules30040898.


β-Glucosidase and Its Application in Bioconversion of Ginsenosides in .

Tran T, Son J, Awais M, Ko J, Yang D, Jung S Bioengineering (Basel). 2023; 10(4).

PMID: 37106671 PMC: 10136122. DOI: 10.3390/bioengineering10040484.


Microorganisms for Ginsenosides Biosynthesis: Recent Progress, Challenges, and Perspectives.

Chu L, Huy N, Tung N Molecules. 2023; 28(3).

PMID: 36771109 PMC: 9921939. DOI: 10.3390/molecules28031437.


Enhanced production of ginsenoside Rh2() from PPD-type major ginsenosides using BglSk cloned from together with two glycosidase in series.

Siddiqi M, Ximenes H, Song B, Park H, Lee W, Han H Saudi J Biol Sci. 2021; 28(8):4668-4676.

PMID: 34354454 PMC: 8324944. DOI: 10.1016/j.sjbs.2021.04.079.

References
1.
YUN T . Panax ginseng--a non-organ-specific cancer preventive?. Lancet Oncol. 2002; 2(1):49-55. DOI: 10.1016/S1470-2045(00)00196-0. View

2.
Xu Q, Fang X, Chen D . Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats. J Ethnopharmacol. 2003; 84(2-3):187-92. DOI: 10.1016/s0378-8741(02)00317-3. View

3.
Tawab M, Bahr U, Karas M, Wurglics M, Schubert-Zsilavecz M . Degradation of ginsenosides in humans after oral administration. Drug Metab Dispos. 2003; 31(8):1065-71. DOI: 10.1124/dmd.31.8.1065. View

4.
Ahmad Q, Nguyen D, Wingerd M, Church G, Steffen M . Molecular weight assessment of proteins in total proteome profiles using 1D-PAGE and LC/MS/MS. Proteome Sci. 2005; 3(1):6. PMC: 1182394. DOI: 10.1186/1477-5956-3-6. View

5.
Chi H, Ji G . Transformation of ginsenosides Rb1 and Re from Panax ginseng by food microorganisms. Biotechnol Lett. 2005; 27(11):765-71. DOI: 10.1007/s10529-005-5632-y. View